

NCT03241368 Raw comparison:

Summary:
CHIA has 21 criteria while your personal folder has 25 criteria
Total found criteria: 18/21
Total not Found: 3/21
Total Extra: 4
This trial is INVALID



╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╕
│ CHIA Criteria                                      │ Matching Personal Criteria                         │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╡
│ Subject has provided informed consent              │ Subject has provided informed consent              │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Subject is ≥ 18 years of age                       │ Subject is ≥ 18 years of age                       │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Subject is willing and able to comply with all     │ Subject is willing and able to comply with all     │
│ aspects of treatment and evaluation schedule       │ aspects of treatment and evaluation schedule       │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Subject has indeterminate ulcerative antibiotic-   │ Subject has indeterminate ulcerative antibiotic-   │
│ associated colitis                                 │ associated colitis                                 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Subject has stool positive for ova and parasite    │ Subject has stool positive for ova and parasite    │
│ and for Clostridium difficule toxins within 3      │ and for Clostridium difficile toxins within 3      │
│ months prior to enrollment                         │ months prior to enrollment                         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Subject with other known infectious cause of       │ Subject with other known infectious cause of       │
│ abdominal symptoms                                 │ abdominal symptoms                                 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Subject with clinical evidence of renal disease    │ Subject with clinical evidence of renal disease    │
│ with the past 6 months defined as estimated        │ with the past 6 months defined as estimated        │
│ glomerular filtration rate (GFR) outside the       │ glomerular filtration rate (GFR) outside the       │
│ normal reference range                             │ normal reference range                             │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Subject with known history of intestinal           │ Subject with known history of intestinal           │
│ obstruction or current obstructive symptoms such   │ obstruction or current obstructive symptoms such   │
│ as severe abdominal pain with accompanying nausea  │ as severe abdominal pain with accompanying nausea  │
│ or vomiting based on investigator judgment         │ or vomiting based on investigator judgment         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Subject with a diagnosis of gastroparesis or small │ Subject with a diagnosis of gastroparesis or small │
│ bowel or large bowel dysmotility                   │ bowel or large bowel dysmotility                   │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Subject has used non-steroidal anti-inflammatory   │ Subject has used non-steroidal anti-inflammatory   │
│ drugs including aspirin two times per week during  │ drugs including aspirin two times per week during  │
│ the 4 weeks preceding enrollment Low dose aspirin  │ the 4 weeks preceding enrollment Low dose aspirin  │
│ regimens (< 100 mg daily) are acceptable and not   │ regimens (≤ 100 mg daily) are acceptable and not   │
│ exclusionary                                       │ exclusionary                                       │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Subject suffers from any condition such as         │ Subject suffers from any condition such as         │
│ swallowing problems that precludes compliance with │ swallowing problems that precludes compliance with │
│ study and/or device instructions                   │ study and/or device instructions                   │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Subject with cardiac pacemaker or other implanted  │ Subject with cardiac pacemaker or other implanted  │
│ electromedical device                              │ electromedical device                              │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Subject has an allergy or other known              │ Subject has an allergy or other known              │
│ contraindication to the medications used in the    │ contraindication to the medications used in the    │
│ study                                              │ study                                              │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Subject is pregnant (documented by a positive      │ Subject is pregnant (documented by a positive      │
│ pregnancy test) or is actively breast-feeding      │ pregnancy test) or is actively breast-feeding      │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Subject is considered to be a part of a vulnerable │ Subject is considered to be a part of a vulnerable │
│ population (eg prisoners or those without          │ population (eg prisoners or those without          │
│ sufficient mental capacity)                        │ sufficient mental capacity)                        │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Subject has a known contraindication to MRE or IC  │ Subject has a known contraindication to MRE or IC  │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Subject has participated in a drug or device       │ Subject has participated in a drug or device       │
│ research study within 30 days of enrollment that   │ research study within 30 days of enrollment that   │
│ may interfere with the subject's safety or ability │ may interfere with the subject's safety or ability │
│ to participate in the study                        │ to participate in the study                        │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Subject has any medical condition that would make  │ Subject has any medical condition that would make  │
│ it unsafe for them to participate per              │ it unsafe for them to participate per              │
│ Investigator's descretion                          │ Investigator's discretion                          │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╛



╒═════════════════════════════════════════════════════════════════════════════════════════════════════╕
│ CHIA Criteria Not Found in Personal                                                                 │
╞═════════════════════════════════════════════════════════════════════════════════════════════════════╡
│ Subject has known CD and a recent history (within last 2 years) of mucosal disease (diagnosis based │
│ on radiologic endoscopic or histological evidence)                                                  │
├─────────────────────────────────────────────────────────────────────────────────────────────────────┤
│ Subjects with a history of small bowel or colonic resection                                         │
├─────────────────────────────────────────────────────────────────────────────────────────────────────┤
│ Subject with any current condition believed to have an increased risk of capsule retention such as  │
│ suspected or known bowel obstruction stricture or fistula                                           │
╘═════════════════════════════════════════════════════════════════════════════════════════════════════╛



╒══════════════════════════════════════════════════════════════════════════════════════════════════╕
│ Extra Personal Criteria                                                                          │
╞══════════════════════════════════════════════════════════════════════════════════════════════════╡
│ Subject with ileostomy or colostomy history of total or subtotal colectomy (including those with │
│ ileosigmoidostomy and ileorectostomy)                                                            │
├──────────────────────────────────────────────────────────────────────────────────────────────────┤
│ Subject with suspected or known bowel obstruction stricture (defined as unequivocal proximal     │
│ upstream dilation equal ≥ 2 5 cm) or fistula                                                     │
├──────────────────────────────────────────────────────────────────────────────────────────────────┤
│ Must have minimum age of 18 Years                                                                │
├──────────────────────────────────────────────────────────────────────────────────────────────────┤
│ Subject has known CD and a recent history (within last 2 years) of mucosal disease (based on     │
│ radiologic endoscopic or histologic evidence) OR known CD and active disease based on clinical   │
│ judgment based on symptoms laboratory data or other clinical information                         │
╘══════════════════════════════════════════════════════════════════════════════════════════════════╛